go to contents

Origimm Biotechnology GmbH, a Sanofi company

Back to list

Facts

Founded
2012
Staff
16
Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health

Profile

Origimm (‘Origins of immunity’) is a biotech company that specializes in the discovery of antigens and dermatological drug targets. The company uses its proprietary technology that employs reverse functional screening to discover and develop breakthrough therapies for the prevention and treatment of skin microbiome-associated diseases such as acne vulgaris and other microbiome-associated infections.

R&D:Origimm's lead program is the development of immune therapy against Propionibacterium acnes to treat acne vulgaris. For further information please visit our website: www.origimm.com

Similar companies in RDM biotech/pharma

Genspeed Biotech GmbH

Organization type
RDM biotech/pharma
Region
Upper Austria
Focus
human health
Details

Zytoprotec GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

Attoquant Diagnostics GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

OncoOne Research

Organization type
RDM biotech/pharma
Region
Lower Austria
Focus
human health
Details

Contact

Leberstraße 20
1110 Wien
Vienna

Contact: Sanja Selak (CEO)
Email: office@origimm.com
Website